I am a
Home I AM A Search Login

Papers of the Week

2022 Nov 28

Expert Rev Med Devices

Post-market, randomized, controlled, prospective study evaluating intrathecal pain medication versus conventional medical management in the non-cancer, refractory, chronic pain population (PROSPER).


Pope JE, Jassal N, Sayed D, Patterson D, McDowell G, Bux A, Lim P, Chang E, Nairizi A, Grodofsky S, Deer TR
Expert Rev Med Devices. 2022 Nov 28.
PMID: 36440473.


Intrathecal therapy has been limited by no randomized prospective studies, particularly for those suffering from non-cancer. Further, no prospective, randomized studies investigating the efficacy, safety, and utilization of the intrathecal polyanalgesic consensus guidelines exist.